| Dr Sean Mc Millan, DO | |
|
2103 Burlington Mount Holly Rd, Burlington, NJ 08016-4157 | |
| (609) 747-9200 | |
| (609) 747-1408 |
| Full Name | Dr Sean Mc Millan |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 19 Years |
| Location | 2103 Burlington Mount Holly Rd, Burlington, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689885816 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 25MB08970000 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care, Inc | Cherry hill, NJ | Home health agency |
| Virtua Home Care At West Jersey | Mount laurel, NJ | Home health agency |
| Virtua Memorial Hospital Of Burlington County | Mount holly, NJ | Hospital |
| Virtua Willingboro Hospital | Willingboro, NJ | Hospital |
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Virtua Our Lady Of Lourdes Hospital | Camden, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 clinical trial for NuThrax (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant), also known as AV7909, with the dosing of the first subject.
Researchers from the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) and the Bindley Bioscience Center at Purdue University have developed a novel approach to automated detection and classification of harmful bacteria in food. The investigators have designed and implemented a sophisticated statistical approach that allows computers to improve their ability to detect the presence of bacterial contamination in tested samples.
ForeverGreen Worldwide Corporation, a leading direct marketing company and provider of health-centered products, today announced the company has received an anti-doping certification from the Banned Substances Control Group for PowerStrips, indicating the product is free of banned substances.
SuperSonic Imagine presented yesterday the validation of a world wide multicentre study, based on European recruitment, confirming the benefit of ShearWave Elastography when added to ultrasound for improved lesion classification.
BN ImmunoTherapeutics, Inc. has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer.
› Verified 4 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 clinical trial for NuThrax (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant), also known as AV7909, with the dosing of the first subject.
Researchers from the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) and the Bindley Bioscience Center at Purdue University have developed a novel approach to automated detection and classification of harmful bacteria in food. The investigators have designed and implemented a sophisticated statistical approach that allows computers to improve their ability to detect the presence of bacterial contamination in tested samples.
ForeverGreen Worldwide Corporation, a leading direct marketing company and provider of health-centered products, today announced the company has received an anti-doping certification from the Banned Substances Control Group for PowerStrips, indicating the product is free of banned substances.
SuperSonic Imagine presented yesterday the validation of a world wide multicentre study, based on European recruitment, confirming the benefit of ShearWave Elastography when added to ultrasound for improved lesion classification.
BN ImmunoTherapeutics, Inc. has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sean Mc Millan, DO 301 Lippincott Dr Ste 410, Marlton, NJ 08053-4197 Ph: (856) 355-0340 | Dr Sean Mc Millan, DO 2103 Burlington Mount Holly Rd, Burlington, NJ 08016-4157 Ph: (609) 747-9200 |
News Archive
Emergent BioSolutions Inc. today announced the initiation of a Phase 2 clinical trial for NuThrax (Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant), also known as AV7909, with the dosing of the first subject.
Researchers from the School of Science at Indiana University-Purdue University Indianapolis (IUPUI) and the Bindley Bioscience Center at Purdue University have developed a novel approach to automated detection and classification of harmful bacteria in food. The investigators have designed and implemented a sophisticated statistical approach that allows computers to improve their ability to detect the presence of bacterial contamination in tested samples.
ForeverGreen Worldwide Corporation, a leading direct marketing company and provider of health-centered products, today announced the company has received an anti-doping certification from the Banned Substances Control Group for PowerStrips, indicating the product is free of banned substances.
SuperSonic Imagine presented yesterday the validation of a world wide multicentre study, based on European recruitment, confirming the benefit of ShearWave Elastography when added to ultrasound for improved lesion classification.
BN ImmunoTherapeutics, Inc. has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer.
› Verified 4 days ago
Dr. Irving P Ratner, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 2103 Burlington Mount Holly Rd, Burlington, NJ 08016 Phone: 609-747-9200 Fax: 609-747-1408 | |
Efrain Paz Jr., DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2103 Burlington Mount Holly Rd, Burlington, NJ 08016 Phone: 609-747-9200 Fax: 609-747-1408 |